European Archives - Page 752 of 1169 - European Medical Journal

Intervention in Malaria Parasite Journey May Reduce Disease Transmission

THE JOURNEY taken by malaria Plasmodium parasites for invasion of the liver may now be detectable, according to a new study…

Delayed Onset of Alzheimer’s Initiated by Anticoagulant in Mice

DELAYED onset of Alzheimer’s disease caused by a well-known anticoagulant has been demonstrated in a mouse model…

Predicting Methotrexate Response in Rheumatoid Arthritis Patients

CHANGES in DNA methylation at 4 weeks of methotrexate treatment for rheumatoid arthritis (RA) were associated with improvements in symptoms at 6 months…

Shedding New Light on Chronic Pain Link to Weather

“AROUND three-quarters of people living with arthritis believe their pain is affected by the weather,” explains Prof Will Dixon…

Review of the European Society for Medical Oncology (ESMO) Congress 2019

Barcelona, a city with undisputed character, ambience, and beauty, played host this year to the prestigious annual European Society…

A Novel Affinity-Enhanced NY-ESO-1-Targeting TCR-Redirected T cell Transfer Exhibiting Early-Onset Cytokine Release Syndrome and Subsequent Tumour Responses in Synovial Sarcoma Patients

Adoptive transfer of T cell receptor (TCR)-redirected T cells has been reported to exhibit efficacy in some patients with melanoma and sarcoma…

Inflection Point: Novel Treatment Options are Forcing Next-Generation Sequencing into Standard of Care for Molecular Profiling in Oncology

With a sustained number of new drugs or combination drugs entering standard of care this year, molecular testing should be…

The Anticancer Power of the Immune System – New Perspectives for Patients with Triple-Negative Breast Cancer

Despite the impressive advances that have been made in cancer diagnosis and therapy, there still exist groups of patients who are not responding to standard anticancer treatments…

A Phase II Study of Pazopanib as Front-Line Therapy in Patients with Nonresectable or Metastatic Soft Tissue Sarcomas Who are Not Candidates for Chemotherapy

Patients with metastatic soft tissue sarcoma (STS) have a poor prognosis with a median survival of 12–14 months.1 First-line therapy consists…

Balancing the Scales: The Fight for Female Representation in Oncology

As exciting and momentous as the progression in medical oncology continues to be, a different type of progression is still sorely needed across…